Clinical trial
An Early-Phase Clinical Study to Evaluate the Tolerability, Safety, and Efficacy of VGN-Ex05e in Patients With Autism Spectrum Disorder (ASD) Associated With Severe, Treatment-Resistant Self-Injurious and Aggressive Behaviors
NCT07433517 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Early-Phase Clinical Study to Evaluate the Tolerability, Safety, and Efficacy of VGN-Ex05e in Patients With Autism Spectrum Disorder (ASD) Associated With Severe, Treatment-Resistant Self-Injurious and Aggressive Behaviors
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- April 30, 2026
- Completion date
- October 31, 2027
- Enrollment
- 6 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.